cyc 202 has been researched along with 2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol) | Trials (2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol) | Recent Studies (post-2010) (2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 10 | 0 | 6 |
| Protein | Taxonomy | cyc 202 (IC50) | 2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol (IC50) |
|---|---|---|---|
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 5.7 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 8.7 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 8.7 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 8.4667 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 8.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanus, J; Havlícek, L; Leclerc, S; Meijer, L; Shaw, G; Strnad, M; Veselý, J | 1 |
| Bravo-Altamirano, K; DeStefino, NR; Liang, M; Mazzarisi, CM; Meriney, SD; Olszewski, RA; Rensch, G; Swanson, L; Tarr, TB; Valdomir, G; Wilson, GM; Wipf, P | 1 |
| Bazgier, V; Berka, K; Gucký, T; Havlíček, L; Jaffe, CL; Jorda, R; Kryštof, V; Nasereddin, A; Popa, A; Popa, I; Řezníčková, E; Strnad, M; Zatloukal, M | 1 |
3 other study(ies) available for cyc 202 and 2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanol
| Article | Year |
|---|---|
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Topics: Animals; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Enzyme Inhibitors; Kinetin; Oocytes; Purines; Roscovitine; Starfish; Tumor Cells, Cultured | 1997 |
Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.
Topics: | 2012 |
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
Topics: Antiprotozoal Agents; Binding Sites; Leishmania donovani; Leishmania major; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Proto-Oncogene Proteins c-crk; Purines; Structure-Activity Relationship | 2015 |